Back to Oncology
Oncologyv2015Evidence-Based

Clinical Index of Stable Febrile Neutropenia (CISNE)

Identifies febrile neutropenia patients at low risk for serious complications. Used for adult outpatients with solid tumor, fever ≥38°C (100.4°F), and neutropenia (≤500 cells/mm³ or ≤1,000 cells/mm³ with expected decrease to 500).

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
cisne score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Clinical Index of Stable Febrile Neutropenia (CISNE) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within oncology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

CISNE Score = ECOG Performance Status points + Stress-induced hyperglycemia points + COPD points + Cardiovascular disease points + NCI mucositis points + Monocyte points

Clinical Pearls & Practice Notes

  • Only for stable patients with solid tumors and febrile neutropenia
  • Not for use in patients who are considered high risk on initial assessment
  • Complications include hypotension, acute organ failure, arrhythmia, major bleeding, acute abdomen, DIC, delirium

Evidence & Literature Citations

  1. Carmona-Bayonas A, Gómez J, González-Billalabeitia E, et al. Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients. Br J Cancer. 2011 Aug 23;105(5):612-7. doi: 10.1038/bjc.2011.284.
  2. Carmona-Bayonas A, Jiménez-Fonseca P, Virizuela Echaburu J, et al. Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study. J Clin Oncol. 2015 Feb 10;33(5):465-71. doi: 10.1200/JCO.2014.57.2347.

Score Interpretation Ranges

Tier 10 – 0 pts

Low risk

Tier 21 – 2 pts

Intermediate risk

Tier 33 – 8 pts

High risk

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.